Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease

被引:52
作者
Zabetian, C. P.
Morino, H.
Ujike, H.
Yamamoto, M.
Oda, M.
Maruyama, H.
Izumi, Y.
Kaji, R.
Griffith, A.
Leis, B. C.
Roberts, J. W.
Yearout, D.
Samii, A.
Kawakami, H.
机构
[1] Ctr Geriatr Res Educ & Clin, VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA
[3] VA Puget Sound Hlth Care Syst, NW Parkinsons Dis Res Educ & Clin Ctr, Seattle, WA USA
[4] Hiroshima Univ, Grad Sch Biomed Sci, Res Inst Radiat Biol & Med, Dept Epidemiol, Hiroshima 730, Japan
[5] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima 730, Japan
[6] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neuropsychiat, Okayama 7008530, Japan
[7] Kagawa Prefectural Cent Hosp, Dept Neurol, Takamatsu, Kagawa, Japan
[8] Sumimoto Hosp, Dept Neurol, Osaka, Japan
[9] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Neurosci, Tokushima 770, Japan
[10] Evergreen Hosp, Med Ctr, Booth Gardner Parkinsons Care Ctr, Kirkland, WA USA
[11] Virginia Mason Med Ctr, Seattle, WA 98101 USA
关键词
D O I
10.1212/01.wnl.0000227732.37801.d4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
LRRK2 G2019S is the most common known cause of Parkinson disease (PD) in patients of European origin, but little is known about its distribution in other populations. The authors identified two of 586 Japanese patients with PD heterozygous for the mutation who shared a haplotype distinct from that observed in Europeans. This suggests that G2019S originated from separate founders in Europe and Japan and is more widely dispersed than previously recognized.
引用
收藏
页码:697 / 699
页数:3
相关论文
共 10 条
[1]   Genetics of Parkinson's disease: LRRK2 on the rise [J].
Brice, A .
BRAIN, 2005, 128 :2760-2762
[2]   An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family [J].
Funayama, M ;
Hasegawa, K ;
Ohta, E ;
Kawashima, N ;
Komiyama, M ;
Kowa, H ;
Tsuji, S ;
Obata, F .
ANNALS OF NEUROLOGY, 2005, 57 (06) :918-921
[3]   The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor -: art. no. e65 [J].
Goldwurm, S ;
Di Fonzo, A ;
Simons, EJ ;
Rohé, CF ;
Zini, M ;
Canesi, M ;
Tesei, S ;
Zecchinelli, A ;
Antonini, A ;
Mariani, C ;
Meucci, N ;
Sacilotto, G ;
Sironi, F ;
Salani, G ;
Ferreira, J ;
Chien, HF ;
Fabrizio, E ;
Vanacore, N ;
Dalla Libera, A ;
Stocchi, F ;
Diroma, C ;
Lamberti, P ;
Sampaio, C ;
Meco, G ;
Barbosa, E ;
Bertoli-Avella, AM ;
Breedveld, GJ ;
Oostra, BA ;
Pezzoli, G ;
Bonifati, V .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (11) :e65
[4]   Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations [J].
Kachergus, J ;
Mata, IF ;
Hulihan, M ;
Taylor, JP ;
Lincoln, S ;
Aasly, J ;
Gibson, JM ;
Ross, OA ;
Lynch, T ;
Wiley, J ;
Payami, H ;
Nutt, J ;
Maraganore, DM ;
Czyzewski, K ;
Styczynska, M ;
Wszolek, ZK ;
Farrer, MJ ;
Toft, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :672-680
[5]   Parkinson's disease and LRRK2:: Frequency of a common mutation in US movement disorder clinics [J].
Kay, DM ;
Zabetian, CP ;
Factor, SA ;
Nutt, JG ;
Samii, A ;
Griffith, A ;
Bird, TD ;
Kramer, P ;
Higgins, DS ;
Payami, H .
MOVEMENT DISORDERS, 2006, 21 (04) :519-523
[6]   LRRK2 haplotype analyses in European and North African families with Parkinson disease:: A common founder for the G2019S mutation dating from the 13th century [J].
Lesage, S ;
Leutenegger, AL ;
Ibanez, P ;
Janin, S ;
Lohmann, E ;
Dürr, A ;
Brice, A .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (02) :330-332
[7]   The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease [J].
Lu, CS ;
Simons, EJ ;
Wu-Chòu, YH ;
Di Fonzo, A ;
Chang, HC ;
Chen, RS ;
Weng, YH ;
Rohé, CF ;
Breedveld, GJ ;
Hattori, N ;
Gasser, T ;
Oostra, BA ;
Bonifati, V .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (08) :521-522
[8]   LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews [J].
Ozelius, LJ ;
Senthil, G ;
Saunders-Pullman, R ;
Ohmann, E ;
Deligtisch, A ;
Tagliati, M ;
Hunt, AL ;
Klein, C ;
Henick, B ;
Hailpern, SM ;
Lipton, RB ;
Soto-Valencia, J ;
Risch, N ;
Bressman, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04) :424-425
[9]   The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients [J].
Tan, EK ;
Shen, H ;
Tan, LCS ;
Farrer, A ;
Yew, K ;
Chua, E ;
Jamora, RD ;
Puvan, K ;
Puong, KY ;
Zhao, Y ;
Pavanni, R ;
Wong, MC ;
Yih, Y ;
Skipper, L ;
Liu, JJ .
NEUROSCIENCE LETTERS, 2005, 384 (03) :327-329
[10]   A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations [J].
Zabetian, CP ;
Samii, A ;
Mosley, AD ;
Roberts, JW ;
Leis, BC ;
Yearout, D ;
Raskind, WH ;
Griffith, A .
NEUROLOGY, 2005, 65 (05) :741-744